113 related articles for article (PubMed ID: 23557600)
1. Direct intranigral administration of an ubiquitin proteasome system inhibitor in rat: behavior, positron emission tomography, immunohistochemistry.
Mackey S; Jing Y; Flores J; Dinelle K; Doudet DJ
Exp Neurol; 2013 Sep; 247():19-24. PubMed ID: 23557600
[TBL] [Abstract][Full Text] [Related]
2. Different effects of intranigral and intrastriatal administration of the proteasome inhibitor lactacystin on typical neurochemical and histological markers of Parkinson's disease in rats.
Lorenc-Koci E; Lenda T; Antkiewicz-Michaluk L; Wardas J; Domin H; Smiałowska M; Konieczny J
Neurochem Int; 2011 Jun; 58(7):839-49. PubMed ID: 21419185
[TBL] [Abstract][Full Text] [Related]
3. Nigrostriatal proteasome inhibition impairs dopamine neurotransmission and motor function in minipigs.
Lillethorup TP; Glud AN; Alstrup AKO; Mikkelsen TW; Nielsen EH; Zaer H; Doudet DJ; Brooks DJ; Sørensen JCH; Orlowski D; Landau AM
Exp Neurol; 2018 May; 303():142-152. PubMed ID: 29428213
[TBL] [Abstract][Full Text] [Related]
4. Early increase in dopamine release in the ipsilateral striatum after unilateral intranigral administration of lactacystin produces spontaneous contralateral rotations in rats.
Konieczny J; Lenda T; Czarnecka A
Neuroscience; 2016 Jun; 324():92-106. PubMed ID: 26964686
[TBL] [Abstract][Full Text] [Related]
5. Monoaminergic PET imaging and histopathological correlation in unilateral and bilateral 6-hydroxydopamine lesioned rat models of Parkinson's disease: a longitudinal in-vivo study.
Molinet-Dronda F; Gago B; Quiroga-Varela A; Juri C; Collantes M; Delgado M; Prieto E; Ecay M; Iglesias E; Marín C; Peñuelas I; Obeso JA
Neurobiol Dis; 2015 May; 77():165-72. PubMed ID: 25681534
[TBL] [Abstract][Full Text] [Related]
6. The Protective Effect of Repeated 1MeTIQ Administration on the Lactacystin-Induced Impairment of Dopamine Release and Decline in TH Level in the Rat Brain.
Wąsik A; Romańska I; Zelek-Molik A; Nalepa I; Antkiewicz-Michaluk L
Neurotox Res; 2018 Oct; 34(3):706-716. PubMed ID: 30129004
[TBL] [Abstract][Full Text] [Related]
7. Decreased behavioral response to intranigrally administered GABAA agonist muscimol in the lactacystin model of Parkinson's disease may result from partial lesion of nigral non-dopamine neurons: comparison to the classical neurotoxin 6-OHDA.
Konieczny J; Czarnecka A; Kamińska K; Lenda T; Nowak P
Behav Brain Res; 2015 Apr; 283():203-14. PubMed ID: 25655509
[TBL] [Abstract][Full Text] [Related]
8. Retrograde dopaminergic neuron degeneration following intrastriatal proteasome inhibition.
Miwa H; Kubo T; Suzuki A; Nishi K; Kondo T
Neurosci Lett; 2005 May 20-27; 380(1-2):93-8. PubMed ID: 15854758
[TBL] [Abstract][Full Text] [Related]
9. Chronic L-DOPA treatment attenuates behavioral and biochemical deficits induced by unilateral lactacystin administration into the rat substantia nigra.
Konieczny J; Czarnecka A; Lenda T; Kamińska K; Lorenc-Koci E
Behav Brain Res; 2014 Mar; 261():79-88. PubMed ID: 24361083
[TBL] [Abstract][Full Text] [Related]
10. Nigral injection of a proteasomal inhibitor, lactacystin, induces widespread glial cell activation and shows various phenotypes of Parkinson's disease in young and adult mouse.
Savolainen MH; Albert K; Airavaara M; Myöhänen TT
Exp Brain Res; 2017 Jul; 235(7):2189-2202. PubMed ID: 28439627
[TBL] [Abstract][Full Text] [Related]
11. [
Weng CC; Huang SL; Chen ZA; Lin KJ; Hsiao IT; Yen TC; Kung MP; Wey SP; Hsu CH
Ann Nucl Med; 2017 Aug; 31(7):506-513. PubMed ID: 28451991
[TBL] [Abstract][Full Text] [Related]
12. [Sleep changes during degeneration of neurons in the substantia nigra induced by inhibitor of proteasomes lactacystin in rats].
Pastukhov IuF; Chesnokova AIu; Iakimchuk AA; Ekimova IV; Romanova IV; Khudik KA
Ross Fiziol Zh Im I M Sechenova; 2010 Dec; 96(12):1190-202. PubMed ID: 21473106
[TBL] [Abstract][Full Text] [Related]
13. Associated degeneration of ventral tegmental area dopaminergic neurons in the rat nigrostriatal lactacystin model of parkinsonism and their neuroprotection by valproate.
Harrison IF; Anis HK; Dexter DT
Neurosci Lett; 2016 Feb; 614():16-23. PubMed ID: 26742637
[TBL] [Abstract][Full Text] [Related]
14. Fine structure and biochemical mechanisms underlying nigrostriatal inclusions and cell death after proteasome inhibition.
Fornai F; Lenzi P; Gesi M; Ferrucci M; Lazzeri G; Busceti CL; Ruffoli R; Soldani P; Ruggieri S; Alessandri MG; Paparelli A
J Neurosci; 2003 Oct; 23(26):8955-66. PubMed ID: 14523098
[TBL] [Abstract][Full Text] [Related]
15. The influence of acute and chronic administration of 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline on the function of the nigrostriatal dopaminergic system in rats.
Lorenc-Koci E; Antkiewicz-Michaluk L; Kamińska A; Lenda T; Zieba B; Wierońska J; Smiałowska M; Schulze G; Rommelspacher H
Neuroscience; 2008 Oct; 156(4):973-86. PubMed ID: 18809471
[TBL] [Abstract][Full Text] [Related]
16. An animal model mimicking pedunculopontine nucleus cholinergic degeneration in Parkinson's disease.
Pienaar IS; Harrison IF; Elson JL; Bury A; Woll P; Simon AK; Dexter DT
Brain Struct Funct; 2015 Jan; 220(1):479-500. PubMed ID: 24292256
[TBL] [Abstract][Full Text] [Related]
17. Systemic LPS-induced neuroinflammation increases the susceptibility for proteasome inhibition-induced degeneration of the nigrostriatal pathway.
Deneyer L; Albertini G; Bentea E; Massie A
Parkinsonism Relat Disord; 2019 Nov; 68():26-32. PubMed ID: 31621614
[TBL] [Abstract][Full Text] [Related]
18. Interpreting DTBZ binding data in rodent: Inherent variability and compensation.
Mejias M; Yu J; Mackey S; Dinelle K; Sossi V; Doudet DJ
Synapse; 2016 Apr; 70(4):147-52. PubMed ID: 26749375
[TBL] [Abstract][Full Text] [Related]
19. Proteasome inhibitor MG-132 induces dopaminergic degeneration in cell culture and animal models.
Sun F; Anantharam V; Zhang D; Latchoumycandane C; Kanthasamy A; Kanthasamy AG
Neurotoxicology; 2006 Sep; 27(5):807-15. PubMed ID: 16870259
[TBL] [Abstract][Full Text] [Related]
20. Early synaptic dysfunction induced by α-synuclein in a rat model of Parkinson's disease.
Phan JA; Stokholm K; Zareba-Paslawska J; Jakobsen S; Vang K; Gjedde A; Landau AM; Romero-Ramos M
Sci Rep; 2017 Jul; 7(1):6363. PubMed ID: 28743955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
